Infectious Disease Puscast #118 from Infectious Disease Puscast

Viral
Alimatravir Oral Once Monthly in Adults With Low Likelihood of HIV Exposure: A Randomized, Double-Blind, Placebo-Controlled Study (JID)
Long-Acting Lenacapavir and Cabotegravir and Viral Suppression Among People With HIV (JAMA: Open Network)
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment (FDA)
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection (NEJM)
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial (Nature Medicine)
Bacterial
A Systematic Review and Network Meta-analysis of Empirical Antibiotics for Complicated Urinary Tract Infections (OFID)
Cephalexin 500 mg Four Times Daily vs. 1000 mg Three Times Daily for the Treatment of Uncomplicated Cellulitis (OFID)
Fungal
The Last of US Season 2 (YouTube)
Performance of the Urinary MycoMEIA Aspergillus Assay as an Aid to Diagnose Invasive Aspergillosis (CID)
Emergence of pan-drug resistant Candidozyma auris in Kenya, the second globally documented case(Scientific Reports)
Parasitic
Artificial Intelligence–Supported Automated Microscopy for Malaria Diagnosis: A Multicenter Study (CID)
Decentralized Diagnostic Platform, miLab™ (noul)
Mapping Hospitals That Treat Severe Malaria Cases in the United States: Evidence to Inform Health Systems Strategies for Intravenous Artesunate Supply (CID)
Locally Acquired Malaria Cases Identified in the United States (CDC: Emergency Preparedness and Response)
ARTESUNATE FOR INJECTION (AMIVAS)
Availability of IV Artesunate for Severe Malaria (CID)
Miscellaneous
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis (NEJM)

Music is by Ronald Jenkees

Information on this podcast should not be considered as medical advice.

← See all 118 episodes of Infectious Disease Puscast